Arora Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 45 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -31.98%
- Profit Growth -17.33%
- Ebitda -44.85%
- Net Worth 9.70%
- Total Assets 4.27%
About Arora Pharmaceuticals
Arora Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 September 1979 and has a history of 45 years and five months. Its registered office is in New Delhi, Delhi.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Murari Arora and Om Kochhar serve as directors at the Company.
Company Details
-
LocationNew Delhi, Delhi
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1979PTC009842
-
Company No.
009842
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Sep 1979
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Arora Pharmaceuticals Private Limited offer?
Arora Pharmaceuticals Private Limited offers a wide range of products and services, including Personal Care, Oral Care, Health Conditions, Mental Wellness, Popular Category, Stomach Care.
Who are the key members and board of directors at Arora Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murari Arora
|
Director | 01-Sep-1979 | Current |
|
Om Kochhar
|
Director | 01-Apr-2011 | Current |
Financial Performance of Arora Pharmaceuticals.
Arora Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 31.98% decrease. The company also saw a substantial fall in profitability, with a 17.33% decrease in profit. The company's net worth moved up by a moderate rise of 9.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arora Pharmaceuticals?
In 2017, Arora Pharmaceuticals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Om Shree Impex Private LimitedOm Kochhar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arora Pharmaceuticals?
Arora Pharmaceuticals has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arora Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arora Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
